一位 Mastodon 用户分享了一篇 Morningstar 关于 Absci 在脱发治疗试验后股价表现的文章链接。该用户幽默地表示愿意接受这种治疗，并且不会有副作用，并指出公司价值大幅上涨。 AI
排序理由 该条目是关于新闻文章的社交媒体帖子，带有幽默的评论，而不是主要新闻事件。
在 Mastodon — fosstodon.org 阅读 →
AI 生成摘要 · Google Gemini · 来自 1 个来源。 我们如何撰写摘要 →
Mastodon 用户开玩笑说脱发治疗试验和股价飙升
本文如何被排名
- Signal score
- 0 / 100
- Composite score across the factors below. Higher = stronger signal that this story matters right now.
- Newsworthiness bucket
- Meme
- 该条目是关于新闻文章的社交媒体帖子，带有幽默的评论，而不是主要新闻事件。
- Source corroboration
- Single-source cluster
- Only one publisher covered this so far. Single-source stories can still rank when the publisher is high-authority, but they lack cross-source corroboration.
- Topics
- other
- Editorial topic classification. Feeds into how the story surfaces on /topic/<slug> hub pages and into the per-entity coverage mix.
- AI-industry relevance
- Low
- Off-topic or adjacent — cluster remains reachable but doesn't surface in AI-industry rankings.
- Story freshness
- 100 days old
- Aged out of breaking-news scoring windows; ranking reflects the durable signal from the full source set.
完整方法见我们的编辑标准。
报道来源 [1]
-
我肯定会打这个疫苗，说实话没有严重副作用，当然公司价值也像“bigly”一样飙升 https://www.morningstar.com/news/dow-jones/20260624
I would take this jab, ngl no serious side effects and of course company values went _way_ up like _bigly_ https://www. morningstar.com/news/dow-jones /202606243000/absci-reports-data-from-trial-for-hair-loss-treatment-prices-100-million-stock-offering # ai # absci # drugdesign #…